Bon Natural Life Ltd SEC filings BON
Bon Natural Life Ltd has 152 filings in SEC EDGAR's recent list, going back to Jul 13, 2020. Its latest annual report, Form 20-F, was filed on Jan 23, 2026 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Sep 23, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Apr 24, 2025 | — |
| CORRESP | Letter to the SEC | Apr 16, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2025 | — |
| EFFECT | Filing | Mar 14, 2025 | — |
| CORRESP | Letter to the SEC | Mar 14, 2025 | — |
| CORRESP | Letter to the SEC | Mar 14, 2025 | — |
| CORRESP | Letter to the SEC | Mar 13, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 10, 2025 | — |
| CORRESP | Letter to the SEC | Mar 6, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2025 | — |
| CORRESP | Letter to the SEC | Mar 3, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 24, 2025 | — |
| CORRESP | Letter to the SEC | Feb 18, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 16, 2025 | — |
| UPLOAD | Letter from the SEC | Nov 26, 2024 | — |
| DRS | Filing | Oct 31, 2024 | — |
| NT 20-F | Filing | Jan 30, 2024 | Sep 30, 2023 |
| UPLOAD | Letter from the SEC | Jun 16, 2023 | — |
| CORRESP | Letter to the SEC | May 15, 2023 | — |
| UPLOAD | Letter from the SEC | May 1, 2023 | — |
| NT 20-F | Filing | Jan 31, 2023 | Sep 30, 2022 |
| EFFECT | Filing | Dec 7, 2022 | — |
| CORRESP | Letter to the SEC | Dec 2, 2022 | — |
| CORRESP | Letter to the SEC | Nov 22, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2022 | — |
| CORRESP | Letter to the SEC | Oct 31, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2022 | — |
| CORRESP | Letter to the SEC | Oct 3, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2022 | — |
| EFFECT | Filing | Jun 23, 2021 | — |
| CERT | Filing | Jun 23, 2021 | — |
| CORRESP | Letter to the SEC | Jun 21, 2021 | — |
| CORRESP | Letter to the SEC | Jun 21, 2021 | — |
| 8-A12B | Filing | Jun 21, 2021 | — |
| CORRESP | Letter to the SEC | Mar 30, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 21, 2021 | — |
| CORRESP | Letter to the SEC | Jan 7, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 6, 2020 | — |
| DRSLTR | Filing | Sep 21, 2020 | — |
| DRS/A | Filing | Sep 21, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2020 | — |
| DRS | Filing | Jul 13, 2020 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- BON (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- Cayman Islands
- Headquarters
- Shaanxi, China
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1816815
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.